|1.||Ohashi, Yuichi: 1 article (07/2013)|
|2.||Suzuki, Takashi: 1 article (07/2013)|
|3.||Toshida, Hiroshi: 1 article (01/2012)|
|4.||Ishizuka, Tetsuya: 1 article (01/2012)|
|5.||Suto, Chikako: 1 article (01/2012)|
|6.||Kamiya, Kazutaka: 1 article (01/2009)|
|7.||Kasahara, Masayuki: 1 article (01/2009)|
|8.||Shimizu, Kimiya: 1 article (01/2009)|
|9.||Matsuzaki, Kaoru: 1 article (02/2005)|
|10.||Sato, Yumie: 1 article (02/2005)|
03/01/1983 - "In the cefmenoxime group, all except one urethral infection were eradicated. "
01/01/1985 - "On the whole, this study showed a significant placental transfer of cefmenoxime, achieving therapeutic concentrations required against microorganisms responsible for obstetrical infections."
05/01/1984 - "On the whole, this study showed a significant placental transfer of cefmenoxime, achieving therapeutic concentrations required against microorganisms responsible for obstetrical infections."
10/01/1982 - "[Laboratory and clinical studies of cefmenoxime in pediatric infections]."
06/01/1982 - "The study group was organized to evaluate the usefulness of cefmenoxime (CMX) injection, a new synthetic cephalosporin, for the treatment of infections in the field of obstetrics and gynecology. "
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/1990 - "Schentag et al studied patients with lower respiratory tract infection treated with cefmenoxime alone and found a significant relationship between time greater than MIC & time to clearance of the pathogen from cultures of the tracheobronchial tree. "
09/01/1988 - "[Study on the effectiveness and safety of cefmenoxime in the treatment of respiratory tract infections. "
11/01/1986 - "[Laboratory and clinical studies on cefmenoxime in respiratory tract infections]."
01/01/1983 - "This bacteriological and pharmacokinetic study was therefore performed in order to evaluate the potency of cefmenoxime in the treatment of respiratory infections. "
09/01/1988 - "The effectiveness and safety of cefmenoxime (CMX) in the treatment of respiratory tract infections were evaluated, mainly in relation to the appearance of hemorrhagic tendency. "
|3.||Urinary Tract Infections (Urinary Tract Infection)
06/01/1985 - "Cefmenoxime (CMX) was intravenously administered to 106 patients with complicated urinary tract infection at a daily dose of 2-4 g for 5 days. "
06/01/1985 - "[Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections]."
02/01/1985 - "Cefmenoxime (CMX), a new semisynthetic antibiotic, was administrated in 29 cases diagnosed as complicated urinary tract infection. "
02/01/1985 - "[Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection]."
01/01/1985 - "[Clinical evaluation of cefmenoxime in chronic complicated urinary tract infection]."
02/01/1986 - "Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis."
05/01/1985 - "[Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis]."
09/01/1985 - "Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis."
02/01/1986 - "In-vivo studies using experimental bacteraemia and meningitis in newborn rats revealed that despite similar drug levels, cefmenoxime had significantly greater bactericidal titres in blood at 6-7 h after administration and bacterial clearance from blood was significantly faster with cefmenoxime than with penicillin G at the end of one day of treatment. "
01/01/1985 - "Two grams of cefmenoxime (CMX) was administered by one-shot intravenous injection to the patients in normal pressure hydrocephalus without meningitis, and the transference of CMX into the cerebrospinal fluid (CSF) from blood was investigated. "
01/01/1993 - "The elimination of cefmenoxime after single and repeated i.v. dosing was studied in 12 patients with severe renal failure and sepsis during continuous haemofiltration. "
07/01/1984 - "Cefmenoxime, a new semisynthetic third-generation cephalosporin, was evaluated in 105 patients (45 men and 60 women) with the following infections: skin or skin structure (33), pulmonary (22), urinary tract (30), and septicemia (20). "
12/01/1989 - "1. Cefmenoxime (CMX) was administered with a dosage regimen of 20-25 mg/kg, 2-3 times daily (40-75 mg/kg/day) by intravenous drip over 30 minutes to 9 neonates with bacterial infections including purulent meningitis and septicemia. "
12/01/1980 - "Its therapeutic efficacy against experimental septicemias in mice was equal to or slightly superior to that of cefotaxime and SCE-1365 when the antibiotics were administered in repeated subcutaneous doses after bacterial challenge. "
06/01/1984 - "[Bacteriologic, clinical and kinetic evaluation of cefmenoxime (SCE 1365) in the treatment of 68 cases of septicemia. "
|5.||Penicillin G (Benzylpenicillin)
|8.||Anti-Bacterial Agents (Antibiotics)
|10.||Cephalosporins (Cephalosporin Antibiotics)
|1.||Drug Therapy (Chemotherapy)
|2.||Gynecologic Surgical Procedures (Gynecologic Surgery)